Abstract
Background and aims: Although the administration of gastroprotective drugs may reduce the risk of gastrointestinal (GI) bleeding due to intake of non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin during chronic treatment, no consensus exists as to whether such co-therapy is effective in short-term prevention, particularly in old age. The aim of our study was to evaluate the risk of bleeding associated with acute and chronic NSAID or aspirin therapy in elderly subjects, and the influence of gastroprotective treatment on such a risk. Methods: The study included 467 elderly NSAID or aspirin users and 1784 non-users, who consecutively underwent upper GI endoscopy. The use of NSAIDs and/or aspirin as well as gastroprotective drugs (misoprostol, H2-blockers, proton pump inhibitors) was evaluated during a structured interview. Upper GI tract bleeding was diagnosed on the basis of symptoms and endoscopic signs of recent hemorrhage. Results: 54.2% of patients were acute and 45.8% chronic users of NSAIDs or aspirin. The risk of bleeding was higher in acute [odds ratio (OR) 4.14, 95% CI 2.97-5.78] than chronic users (OR 1.71, 95% CI 1.1-2.67). The risk of bleeding, adjusted for age, gender, Helicobacter (H) pylori infection, and gastroprotective drug use were 7.87 (CI 4.90-12.60) in acute users and 3.97 (95% CI 2.27-6.96) in chronic users of NSAIDs and/or aspirin. The risk of bleeding was significantly associated with acute but not chronic use of regular-dose aspirin (OR 5.53, 95% CI 2.29-13.3), diclofenac (OR 4.44, 95% CI 2.21-8.93), ketorolac (OR 4.81, 95% CI 2.13-10.9), naproxen (OR 14.9, 95% CI 4.23-52.4) or nimesulide (OR 4.06, 95% CI 1.2-13.8). Piroxicam increased the risk of bleeding in both acute (OR 5.36, 95% CI 1.94-14.8) and chronic therapy (OR 5.53, 95% CI 1.23-24.9). In acute users, concomitant therapy with proton pump inhibitors reduced the risk of bleeding compared with non-users (OR 1.05, 95% CI 0.19-5.65), whereas co-treatment with H2-blockers was associated with a significantly higher risk of bleeding than in non-users (OR 3.40, 95% CI 1.28-9.02). Chronic users of NSAIDs or aspirin co-treated with proton pump inhibitors had a lower risk of bleeding (OR 1.12, 95% CI 0.21-6.07) than those treated with misoprostol (OR 1.91, 95% CI 0.33-10.9) or H2 blockers (OR 2.26, 95% CI 0.81-6.36). Conclusions: The risk of upper GI bleeding is significantly higher in elderly acute vs chronic users of NSAIDs or regular-dose aspirin. In acute NSAID or aspirin users, co-treatment with proton pump inhibitors, but not with H2-blockers, may reduce the risk of bleeding compared with non-users.
Similar content being viewed by others
References
Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888–99.
Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual nonsteroidal antiinflammatory drugs. Lancet 1994; 343: 1075–8.
Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998; 158: 33–9.
Pilotto A, Franceschi M, Leandro G, Di Mario F, on behalf of the Geriatric Gastroenterology Study Group(Societä Italiana di Gerontologia e Geriatria, SIGG). NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies. Drugs Aging 2003; 20: 701–10.
Reidemberg MM. Drug therapy by the elderly. The problem from the point of view of a clinical pharmacologist. Clin Pharmacol Ther 1987; 42: 677–80.
Guslandi M, Pellegrini A, Sorghi M. Gastric mucosal defences in the elderly. Gerontology 1999; 45: 206–8.
Beard K, Walker AM, Poerera DR, Jick H. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med 1987; 147: 1621–3.
Kemppainen H, Raiha I, Sourander L. Clinical presentation of bleeding peptic ulcer in the elderly. Aging Clin Exp Res 1996; 8: 184–8.
Pilotto A, Franceschi M, Leandro G, Di Mario F, Valerio G. The effect of Helicobacter pylori infection on NSAID-related gastro-duodenal damage in the elderly. Eur J Gastroenterol Hepatol 1997; 9: 951–6.
Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997; 42: 586–91.
Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal antiinflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123: 241–9.
Hudson N, Taha AS, Russel RI, et al. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology 1997; 112: 1817–22.
Cullen D, Bardhan KD, Eisner M, et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal antiinflammatory drug users. Aliment Pharmacol Ther 1998; 12: 135–40.
Yeomans ND, Karrash JA, Szczepanski L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1998; 338: 719–26.
Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338: 727–34.
Koch M, Dezi A, Ferrario F, Capurso L. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Arch Intern Med 1996; 156: 2321–32.
Leandro G, Pilotto A, Franceschi M, Bertin T, Lichino E, Di Mario F. Prevention of acute NSAID-related gastroduodenal damage. A meta-analysis of controlled clinical trials. Dig Dis Sci 2001; 46: 1924–36.
Cotton P, Williams CB. Practical gastrointestinal endoscopy. Oxford: Blackwell Scientific Publications, 3rd ed, 1990.
Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994; 331: 717–27.
Pilotto A, Franceschi M, Rassu M, et al. The non-invasive diagnosis of H pylori infection in older subjects: comparison of 13C-urea breath test with serology. J Gerontol 2000; 55: M163–7.
Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257–63.
Lanas A, Bajador E, Serrano P, et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000; 343: 834–9.
Lipscomb GR, Campbell F, Rees WDW. The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to nonsteroidal antiinflammatory drugs. Aliment Pharmacol Ther 1997; 11: 907–12.
Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JE. Gastrointestinal tract complications of nonsteroidal antiinflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med 1996; 156: 1530–6.
Pilotto A, Di Mario F, Franceschi M, et al. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. Aliment Pharmacol Ther 2000; 14: 1077–82.
Clayton NM, Oakley L, Williams LV, Trevethick MA. The role of acid in the pathogenesis of indomethacin-induced gastric antral ulcers in the rat. Aliment Pharmacol Ther 1996; 10: 339–45.
Chan FK, Sung JJ. Role of acid suppressants in prophylaxis of NSAID damage. Baillière’s Best Pract Res Clin Gastroenterol 2001; 15: 433–45.
Piette F, Teillet L, Naudin R, et al. Efficacy of misoprostol in the prophylaxis of gastroduodenal lesions induced by short-term nonsteroidal antiinflammatory drug therapy in elderly patients. A multicentre double-blind, placebo-controlled trial. Rev Rheum Engl Ed 1997; 64: 259–66.
Scharf S, Kwiatek R, Ugoni A, Christophidis N. NSAlDs and faecal blood loss in elderly patients with osteoarthritis: is plasma halflife relevant? Aust NZ J Med 1998; 28: 436–9.
Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 1413–6.
Chan FKL, Chung SCS, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967–73.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pilotto, A., Franceschi, M., Leandro, G. et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal antiinflammatory drugs: The role of gastroprotective drugs. Aging Clin Exp Res 15, 494–499 (2003). https://doi.org/10.1007/BF03327372
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03327372